The BISTRO Trial
BioImpedance Spectroscopy To Maintain Renal Output
Summary
BISTRO is an NIHR HTA funded pragmatic, multicentre randomised controlled trial to determine if incorporation of bioimpedance into the setting of the post dialytic weight reduces loss of residual kidney function in incident centre-based HD patients, with the potential to improve clinical outcomes, in particular dialysis related symptoms, hospitalisation and survival.
| Cheif Investigator: | Professor Simon Davies |
| Associate Investigator: | |
| Trial Manager: | Dr Nancy Fernandes da Silva |
| Sponsor / Reference Number: | Keele University / RG_0012_16_IACS |
| Funder / Reference Number: | NIHR Health Technology Assessment (HTA) Programme / 14/216/01 |
| UKCRN Study Portfolio Reference Number: | 31766 |
| Registration Reference Number: | ISRCTN11342007 |
| Start Date: | 01 Jun 2016 |
| End Date: | 31 Jan 2022 |
Study Design
This is a Pragmatic, Multicentre, Open-Label Prospective Randomised Controlled Trial.